Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1
Laekna Limited
Laekna Limited
Merck Sharp & Dohme LLC
Inspirna, Inc.
Dana-Farber Cancer Institute
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
GOG Foundation
National Cancer Institute (NCI)